n-acetylneuraminosyl(alpha2-6)lactosamine has been researched along with Grippe in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lerner, RA; Lin, CW; Nycholat, CM; Paulson, JC; Thompson, AJ; Wilson, IA; Wu, NC; Xie, J; Zhu, X | 1 |
| Kadokawa, JI; Koizumi, A; Kuwano, N; Ogata, M; Sawada, T; Sugiyama, N; Takaha, T; Umemura, S; Usui, T; Yanase, M | 1 |
2 other study(ies) available for n-acetylneuraminosyl(alpha2-6)lactosamine and Grippe
| Article | Year |
|---|---|
A complex epistatic network limits the mutational reversibility in the influenza hemagglutinin receptor-binding site.
Topics: Antigens, Viral; Binding Sites; Epistasis, Genetic; HEK293 Cells; Hemagglutinin Glycoproteins, Influenza Virus; Humans; Hydrogen Bonding; Immune System; Influenza A Virus, H3N2 Subtype; Influenza, Human; Mutation; Oligosaccharides; Protein Binding; Receptors, Virus | 2018 |
Synthesis of multivalent sialyllactosamine-carrying glyco-nanoparticles with high affinity to the human influenza virus hemagglutinin.
Topics: Antiviral Agents; Dextrins; Glucuronic Acid; Hemagglutination Inhibition Tests; Hemagglutinin Glycoproteins, Influenza Virus; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; N-Acetylneuraminic Acid; Nanoparticles; Oligosaccharides | 2016 |